| Dr Ramon F Torrado-frias, MD | |
|
Calle Rodriguez Irizarry 150, Arecibo, PR 00612 | |
| (787) 878-3522 | |
| (787) 878-3776 |
| Full Name | Dr Ramon F Torrado-frias |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 35 Years |
| Location | Calle Rodriguez Irizarry 150, Arecibo, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578550117 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 10329 (Puerto Rico) | Primary |
| Entity Name | Northern Infusion Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083817027 PECOS PAC ID: 4789773235 Enrollment ID: O20080118000003 |
News Archive
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Pulitzer Prize-winning author David Oshinsky examines the development of the world's first polio vaccine, noting that the vaccine, developed by Jonas Salk of the University of Pittsburgh, turned 57 on Thursday.
The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.
Aldo Zini, president of the nation's leading developer of autonomous mobile robots in healthcare, told his fellow executives that mobile robots must be part of a "whole-product solution" if they are to gain relevance and acceptance in the market place.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd. today announced that Acetadote (acetylcysteine) Injection, an injectable product used to treat acetaminophen (paracetamol) overdose, is now commercially available in the Australian market. Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, has an exclusive license from U.S.-based Cumberland Pharmaceuticals to market and distribute the product in Australia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ramon F Torrado-frias, MD Po Box 1065, Arecibo, PR 00613-1065 Ph: (787) 878-3522 | Dr Ramon F Torrado-frias, MD Calle Rodriguez Irizarry 150, Arecibo, PR 00612 Ph: (787) 878-3522 |
News Archive
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Pulitzer Prize-winning author David Oshinsky examines the development of the world's first polio vaccine, noting that the vaccine, developed by Jonas Salk of the University of Pittsburgh, turned 57 on Thursday.
The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.
Aldo Zini, president of the nation's leading developer of autonomous mobile robots in healthcare, told his fellow executives that mobile robots must be part of a "whole-product solution" if they are to gain relevance and acceptance in the market place.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd. today announced that Acetadote (acetylcysteine) Injection, an injectable product used to treat acetaminophen (paracetamol) overdose, is now commercially available in the Australian market. Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, has an exclusive license from U.S.-based Cumberland Pharmaceuticals to market and distribute the product in Australia.
› Verified 1 days ago
Francisco Garcia-cortes, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 47 Calle Morell Campos, Arecibo, PR 00612 Phone: 787-878-9300 Fax: 787-879-3372 | |
Juan C Peraza Delgado, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 258 Calle Ventura Gandarilla, Arecibo, PR 00612 Phone: 787-878-4150 | |
Melvyn Acosta-ruiz Sr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 53 Calle Domingo Rubio, Arecibo, PR 00612 Phone: 787-878-3304 Fax: 787-878-3304 | |
Jose R Davila-torres, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 53 Calle Andres Garcia, Instituto Del Cancer Y Enfermedades De La Sangre, Arecibo, PR 00612 Phone: 787-817-4973 Fax: 787-817-4997 | |
Luis Rafael Gonzalez, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 58 Ave Barbosa, 58, Arecibo, PR 00612 Phone: 787-878-1908 Fax: 787-878-0421 | |
Mrs. Sandra E Betancourt, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Urb San Lorenzo Calle Pedro Mora, Suite 1, Arecibo, PR 00612 Phone: 787-817-2512 Fax: 787-816-7364 | |
Dr. Victor Luis Perez-gonzalez, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: Urb Villa Los Santos Calle 16 V 1, Arecibo, PR 00612 Phone: 787-879-1585 |